Compile Data Set for Download or QSAR
Report error Found 198 Enz. Inhib. hit(s) with all data for entry = 13097
TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757731(US20250230129, Compound 8)
Affinity DataKi:  0.0900nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757737(US20250230129, Compound 13-2)
Affinity DataKi:  0.130nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757736(US20250230129, Compound 13)
Affinity DataKi:  0.130nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757763(US20250230129, Compound 38)
Affinity DataKi:  0.170nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757760(US20250230129, Compound 35)
Affinity DataKi:  0.180nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757742(US20250230129, Compound 18)
Affinity DataKi:  0.210nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757779(US20250230129, Compound 3A)
Affinity DataKi:  0.260nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757740(US20250230129, Compound 16)
Affinity DataKi:  0.260nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757775(US20250230129, Compound 50)
Affinity DataKi:  0.270nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757764(US20250230129, Compound 39)
Affinity DataKi:  0.270nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757771(US20250230129, Compound 46)
Affinity DataKi:  0.290nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757780(US20250230129, Compound 4A)
Affinity DataKi:  0.300nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757784(US20250230129, Compound 8A)
Affinity DataKi:  0.310nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757751(US20250230129, Compound 26)
Affinity DataKi:  0.310nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757746(US20250230129, Compound 21)
Affinity DataKi:  0.330nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757788(US20250230129, Compound 12A)
Affinity DataKi:  0.340nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757781(US20250230129, Compound 5A)
Affinity DataKi:  0.340nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757778(US20250230129, Compound 2A)
Affinity DataKi:  0.340nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757776(US20250230129, Compound 51)
Affinity DataKi:  0.350nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757747(US20250230129, Compound 22)
Affinity DataKi:  0.350nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757749(US20250230129, Compound 24)
Affinity DataKi:  0.360nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757748(US20250230129, Compound 23)
Affinity DataKi:  0.360nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757785(US20250230129, Compound 9A)
Affinity DataKi:  0.370nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757777(US20250230129, Compound 1A)
Affinity DataKi:  0.400nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757762(US20250230129, Compound 37)
Affinity DataKi:  0.410nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757789(US20250230129, Compound 1B)
Affinity DataKi:  0.420nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757782(US20250230129, Compound 6A)
Affinity DataKi:  0.430nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757741(US20250230129, Compound 17)
Affinity DataKi:  0.440nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757750(US20250230129, Compound 25)
Affinity DataKi:  0.450nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757767(US20250230129, Compound 42)
Affinity DataKi:  0.470nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757787(US20250230129, Compound 11A)
Affinity DataKi:  0.480nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757786(US20250230129, Compound 10A)
Affinity DataKi:  0.480nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757772(US20250230129, Compound 47)
Affinity DataKi:  0.490nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757770(US20250230129, Compound 45)
Affinity DataKi:  0.520nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757735(US20250230129, Compound 12)
Affinity DataKi:  0.530nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757769(US20250230129, Compound 44)
Affinity DataKi:  0.550nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757758(US20250230129, Compound 33)
Affinity DataKi:  0.560nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757766(US20250230129, Compound 41)
Affinity DataKi:  0.570nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757745(US20250230129, Compound 20)
Affinity DataKi:  0.580nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757765(US20250230129, Compound 40)
Affinity DataKi:  0.580nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757757(US20250230129, Compound 32)
Affinity DataKi:  0.580nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757759(US20250230129, Compound 34)
Affinity DataKi:  0.600nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757783(US20250230129, Compound 7A)
Affinity DataKi:  0.600nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757754(US20250230129, Compound 29)
Affinity DataKi:  0.630nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757739(US20250230129, Compound 15)
Affinity DataKi:  0.830nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757733(US20250230129, Compound 10)
Affinity DataKi:  0.860nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757752(US20250230129, Compound 27)
Affinity DataKi:  0.880nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757744(US20250230129, Compound 19)
Affinity DataKi:  0.900nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757790(US20250230129, Compound 2B)
Affinity DataKi:  0.910nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
Jiangsu Nhwa Pharmaceutical Co.

US Patent
LigandPNGBDBM757774(US20250230129, Compound 49)
Affinity DataKi:  0.930nMAssay Description:Step 1: 50 μL of a vehicle (1% DMSO) was added into a total binding tube (TB), 50 μL of U69593 (with a final concentration of 1.0×10−5 M) was added i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/30/2025
Entry Details
US Patent

Displayed 1 to 50 (of 198 total ) | Next | Last >>
Jump to: